Compare MESO & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | IMKTA |
|---|---|---|
| Founded | 2004 | 1963 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2005 | 1994 |
| Metric | MESO | IMKTA |
|---|---|---|
| Price | $13.68 | $84.96 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | ★ 255.3K | 78.2K |
| Earning Date | 08-26-2026 | 11-25-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $5,334,032,609.00 |
| Revenue This Year | $51.63 | N/A |
| Revenue Next Year | $63.39 | N/A |
| P/E Ratio | ★ N/A | $15.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.89 | $67.92 |
| 52 Week High | $21.50 | $95.62 |
| Indicator | MESO | IMKTA |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 49.30 |
| Support Level | $11.89 | $82.12 |
| Resistance Level | $16.03 | $89.28 |
| Average True Range (ATR) | 0.50 | 1.98 |
| MACD | 0.07 | -0.11 |
| Stochastic Oscillator | 40.72 | 42.54 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.